Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadolol versus placebo for resting energy expenditure in liver cirrhosis
ACTRN12607000546459Phase 2Completed
- Sponsor
- Associate Professor Lindsay Plank
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nadolol in Cirrhosis (2 arms), sponsored by Associate Professor Lindsay Plank. Primary endpoint: Change in resting energy expenditure. Started Aug 2008; status: completed.
02
Drugs
nadolol
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ACTRN12607000546459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000546459.